Novel oral anticoagulant use in adults with congenital heart disease: a single-center experience report.

Daniel SamaraiNazim IsmaSandra LindstedtJoanna Hlebowicz

Published in: The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology (2023)

The results of our study, although limited in size, suggest that NOAC appear safe and effective in ACHD patients. Further and larger studies on NOAC in ACHD patients are warranted.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis
atrial fibrillation
oral anticoagulants